Cargando…
Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy
BACKGROUND: Excellent dosimetric characteristics were demonstrated for volumetric modulated arc therapy (VMAT) in preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC). In a single-center retrospective analysis, we tested whether these advantages may translate into significa...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617910/ https://www.ncbi.nlm.nih.gov/pubmed/26486986 http://dx.doi.org/10.1186/s12885-015-1812-x |
_version_ | 1782396861153280000 |
---|---|
author | Dröge, Leif Hendrik Weber, Hanne Elisabeth Guhlich, Manuel Leu, Martin Conradi, Lena-Christin Gaedcke, Jochen Hennies, Steffen Herrmann, Markus Karl Rave-Fränk, Margret Wolff, Hendrik Andreas |
author_facet | Dröge, Leif Hendrik Weber, Hanne Elisabeth Guhlich, Manuel Leu, Martin Conradi, Lena-Christin Gaedcke, Jochen Hennies, Steffen Herrmann, Markus Karl Rave-Fränk, Margret Wolff, Hendrik Andreas |
author_sort | Dröge, Leif Hendrik |
collection | PubMed |
description | BACKGROUND: Excellent dosimetric characteristics were demonstrated for volumetric modulated arc therapy (VMAT) in preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC). In a single-center retrospective analysis, we tested whether these advantages may translate into significant clinical benefits. We compared VMAT to conventional 3D conformal radiotherapy (3DCRT) in patients, homogeneously treated according to the control arm of the CAO/ARO/AIO-04 trial. METHODS: CRT consisted of pelvic irradiation with 50.4/1.8Gy by VMAT (n = 81) or 3DCRT (n = 107) and two cycles of 5-fluorouracil. Standardized total mesorectal excision surgery was performed within 4–6 weeks. The tumor regression grading (TRG) was assessed by the Dworak score. Acute and late toxicity were evaluated via the Common Terminology Criteria for Adverse Events and the Late effects of normal tissues scale, respectively. Side effects greater than or equal to grade 3 were considered high-grade. RESULTS: Median follow-up was 18.3 months in the VMAT group and 61.5 months in the 3DCRT group with no differences in TRG between them (p = 0.1727). VMAT treatment substantially reduced high-grade acute and late toxicity, with 5 % versus 20 % (p = 0.0081) and 6 % vs. 22 % (p = 0.0039), respectively. With regard to specific organs, differences were found in skin reaction (p = 0.019) and proctitis (p = 0.0153). CONCLUSIONS: VMAT treatment in preoperative CRT for LARC showed the potential to substantially reduce high-grade acute and late toxicity. Importantly, we could demonstrate that VMAT irradiation did not impair short-term oncological results. We conclude, that the reduced toxicity after VMAT irradiation may pave the way for more efficient systemic therapies, and hopefully improved patient survival in the multimodal treatment of LARC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1812-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4617910 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46179102015-10-25 Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy Dröge, Leif Hendrik Weber, Hanne Elisabeth Guhlich, Manuel Leu, Martin Conradi, Lena-Christin Gaedcke, Jochen Hennies, Steffen Herrmann, Markus Karl Rave-Fränk, Margret Wolff, Hendrik Andreas BMC Cancer Research Article BACKGROUND: Excellent dosimetric characteristics were demonstrated for volumetric modulated arc therapy (VMAT) in preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC). In a single-center retrospective analysis, we tested whether these advantages may translate into significant clinical benefits. We compared VMAT to conventional 3D conformal radiotherapy (3DCRT) in patients, homogeneously treated according to the control arm of the CAO/ARO/AIO-04 trial. METHODS: CRT consisted of pelvic irradiation with 50.4/1.8Gy by VMAT (n = 81) or 3DCRT (n = 107) and two cycles of 5-fluorouracil. Standardized total mesorectal excision surgery was performed within 4–6 weeks. The tumor regression grading (TRG) was assessed by the Dworak score. Acute and late toxicity were evaluated via the Common Terminology Criteria for Adverse Events and the Late effects of normal tissues scale, respectively. Side effects greater than or equal to grade 3 were considered high-grade. RESULTS: Median follow-up was 18.3 months in the VMAT group and 61.5 months in the 3DCRT group with no differences in TRG between them (p = 0.1727). VMAT treatment substantially reduced high-grade acute and late toxicity, with 5 % versus 20 % (p = 0.0081) and 6 % vs. 22 % (p = 0.0039), respectively. With regard to specific organs, differences were found in skin reaction (p = 0.019) and proctitis (p = 0.0153). CONCLUSIONS: VMAT treatment in preoperative CRT for LARC showed the potential to substantially reduce high-grade acute and late toxicity. Importantly, we could demonstrate that VMAT irradiation did not impair short-term oncological results. We conclude, that the reduced toxicity after VMAT irradiation may pave the way for more efficient systemic therapies, and hopefully improved patient survival in the multimodal treatment of LARC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1812-x) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-20 /pmc/articles/PMC4617910/ /pubmed/26486986 http://dx.doi.org/10.1186/s12885-015-1812-x Text en © Dröge et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Dröge, Leif Hendrik Weber, Hanne Elisabeth Guhlich, Manuel Leu, Martin Conradi, Lena-Christin Gaedcke, Jochen Hennies, Steffen Herrmann, Markus Karl Rave-Fränk, Margret Wolff, Hendrik Andreas Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy |
title | Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy |
title_full | Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy |
title_fullStr | Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy |
title_full_unstemmed | Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy |
title_short | Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy |
title_sort | reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3d conformal radiotherapy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617910/ https://www.ncbi.nlm.nih.gov/pubmed/26486986 http://dx.doi.org/10.1186/s12885-015-1812-x |
work_keys_str_mv | AT drogeleifhendrik reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy AT weberhanneelisabeth reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy AT guhlichmanuel reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy AT leumartin reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy AT conradilenachristin reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy AT gaedckejochen reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy AT henniessteffen reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy AT herrmannmarkuskarl reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy AT ravefrankmargret reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy AT wolffhendrikandreas reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy |